Prospective scenarios

Your treatment will be tailored to your needs, so the final cost will depend on them and be tailored to your specific clinical situation. The planned or recommended treatment will be discussed with you, including its cost.

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.

As part of the in vitro fertilisation procedure, we provide a time-lapse incubator culture system. All embryos in the laboratory are under the eye of cameras which show their development minute by minute, without the need to take them out of the incubator to assess cell divisions. This system allows for an uninterrupted course of embryonic development and comprehensive documentation of its stages, which is also recorded on an electronic medium and handed over to patients. We also use the RI Witness system, ensuring independent supervision of all stages of the in vitro fertilisation procedure. This system allows for identification, tracking, and keeping a register of germ cells and embryos at each stage of the procedure in the embryology laboratory, as well as during transfer, freezing, storage, and subsequent transfer of thawed embryos.

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.

** Assuming three visits during monitoring. The final number of visits depends on the course of stimulation.

Under the "Successful IVF" treatment programme, patients are provided with (in addition to the elements of scenario 3) all embryo transfers of fresh and frozen embryos until the end of the programme (end of the programme defined as earlier: confirmed clinical pregnancy after transfer or use of the last embryo from that treatment cycle). This is the primary difference in service provision between scenario three and scenario four.

—

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.

** Assuming three visits during monitoring. The final number of visits depends on the course of stimulation.

For patients who would like to preserve their fertility potential for the future, the centre has prepared a special offer (qualification criteria for the programme AMH 1.5 ng/ml and FSH below 10 IU/ml). If the patient does not accumulate at least 12 oocytes in two cycles (guaranteeing a high chance of pregnancy in the future), the third cycle of stimulation will be carried out at the centre for free.

* This is the maximum amount, assuming that patients do not have any problematic results (blood group, valid virological tests, swabs, etc.). In practice, it is much lower.